Shandong Xinhua Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zibo, Shandong and currently employs 7,296 full-time employees. Shandong Xinhua Pharmaceutical Co Ltd is a China-based company mainly engaged in the development, manufacturing and sales of chemical raw materials, pharmaceutical preparations and chemical products. The firm operates three segments. The Chemical Raw Materials segment is mainly engaged in the development, manufacturing and sales of raw materials for antipyretics and analgesics such as caffeine series, ibuprofen series, aspirin series, dopamine series, barbiturates and pipemidic acid. The Pharmaceutical Preparations segment is mainly engaged in the development, manufacturing and sales of tablets, injections and capsules such as pipemidic acid tablets, aminopyrine and nimodipine tablets. The Pharmaceutical Intermediates and Other Products segment is mainly engaged in the development, manufacturing and sales of pharmaceutical intermediates and other products. The firm mainly operates its business in the domestic market and overseas markets such as the Americas and Europe.
SHANDONG XINHUA PHARMACEUTICAL 의 현재 가격은 $18.19이며, 전 거래일에 감소된 0% 하였습니다.
Shandong Xinhua Pharmaceutical Company Limited의 주요 사업 주제나 업종은 무엇입니까?
Shandong Xinhua Pharmaceutical Company Limited은 Pharmaceuticals 업종에 속하며, 해당 부문은 Health Care입니다
Shandong Xinhua Pharmaceutical Company Limited의 시가총액은 얼마입니까?
Shandong Xinhua Pharmaceutical Company Limited의 현재 시가총액은 $899.9M입니다
Shandong Xinhua Pharmaceutical Company Limited는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 3명의 분석가가 Shandong Xinhua Pharmaceutical Company Limited에 대한 분석 평가를 실시했으며, 이는 0명의 강력한 매수, 0명의 매수, 2명의 보유, 3명의 매도, 그리고 0명의 강력한 매도를 포함합니다